Kinase Substrate Arrays for Pharmacological Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting patient response to kinase inhibitors are indirect and unreliable, often relying on gene expression signatures that are not directly related to the mechanism of action and are sensitive to tumor heterogeneity and sample quality, leading to inefficiencies in drug development and treatment.
Innovation Solution
A method using arrays of peptide kinase substrates immobilized on a porous matrix to determine pharmacological profiles by comparing kinase inhibitor responses in the presence and absence of the inhibitor, allowing for the distinction between responders and non-responders through the ratio of substrate responses, specifically utilizing peptide kinase substrates with defined sequence numbers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If gene expression signatures are used to predict patient response, then the method can be applied to complex biological systems, but the measurement is indirect and unreliable since it relies on protein abundance rather than functional activity
Solution Approach 1:
The patent replaces indirect gene expression-based prediction with direct biochemical measurement using activity-based protein profiling. Instead of inferring function from abundance, the method directly measures kinase activity through substrate phosphorylation, substituting the indirect mechanical/gene-expression-based system with a direct biochemical assay system that provides reliable functional data.
Solution Approach 2:
The patent introduces fluorescently labeled substrate peptides as intermediaries to detect kinase activity. These substrates serve as mediators between the kinase enzymes and the detection system, allowing direct visualization and measurement of phosphorylation activity, thereby bridging the gap between protein function and measurable output.
2Ease of manufacture
If protein abundance methods are used, then the analysis can be performed on existing samples, but the method fails to capture dynamic protein function and post-transcriptional regulation
Solution Approach 1:
The patent changes the measurement parameter from protein abundance (static quantity) to kinase activity (dynamic functional output). By measuring substrate phosphorylation rates and using fluorescent signals that report on enzymatic activity, the method captures dynamic functional states and post-transcriptional regulation, transforming the analysis from static to dynamic.
Solution Approach 2:
The patent employs fluorescently labeled substrates that undergo color/fluorescence changes upon phosphorylation. This visual and detectable change provides direct, real-time evidence of kinase activity, making functional assessment both reliable and easily measurable through fluorescence detection.
3Productivity
If kinase inhibitors are tested using traditional methods, then the compound can be evaluated, but the method cannot reliably distinguish between responders and non-responders
Solution Approach 1:
The patent segments the kinase inhibitor testing into parallel assays using multiple substrate peptides that represent different kinase targets and signaling pathways. By simultaneously measuring inhibition across multiple substrates, the method identifies specific response patterns that distinguish responders from non-responders, improving both efficiency and accuracy.
Solution Approach 2:
The patent establishes a feedback loop where substrate phosphorylation levels serve as real-time readouts of kinase inhibitor activity. This feedback mechanism allows direct observation of drug effect on kinase function, enabling reliable prediction of patient response based on measured inhibition patterns rather than indirect inference.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a direct measure of kinase inhibitor mechanism of action and achieves an overall accuracy of 82% in discriminating responder and non-responder cell lines, indicating its potential for predicting patient responses and optimizing drug treatment.
Implementation Method 1
the phosphorylation of the peptide substrates is determined using fluorescently labeled anti-phosphotyrosine antibodies
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention is concerned with method for pharmacologically profiling compounds using an array of substrates, in particular kinase substrates, immobilized on a porous matrix. This method was found particular useful in the prediction of drug response, i.e. to enable the distinction between responders and non-responders in the treatment of cells, tissues, organs or warm-blooded animals with the compound to be tested, and in compound differentiation.